LeadIQ logo
Learn more at LeadIQ.com

Insights

Biotech Funding Insilico Medicine secured $110M in Series E funding, indicating financial stability and potential for investment in innovative drug discovery solutions.

AI Public Offering With plans for an IPO and a valuation surpassing $1 billion, Insilico Medicine's AI-driven approach presents investment opportunities in cutting-edge drug development.

Strategic Partnerships Collaborations with industry leaders like AZO Life Sciences and Harbour BioMed position Insilico Medicine as an attractive partner for AI-powered drug discovery solutions.

Market Expansion Developing drugs for various indications, including oncology, fibrosis, and aging-related diseases, presents sales opportunities in diverse and high-demand therapeutic areas.

Tech Stack Utilization Utilizing advanced technologies like TensorFlow and generative AI models enhances Insilico Medicine's capabilities, making them an appealing choice for clients seeking cutting-edge solutions.

Insilico Medicine Tech Stack

Insilico Medicine uses 8 technology products and services including Linkedin Insight Tag, Tilda, Google Font API, and more. Explore Insilico Medicine's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • Tilda
    Content Management System
  • Google Font API
    Font Scripts
  • TensorFlow
    Machine Learning
  • DDoS-Guard
    Security
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

Insilico Medicine's Email Address Formats

Insilico Medicine uses at least 2 format(s):
Insilico Medicine Email FormatsExamplePercentage
F.Last@insilicomedicine.comJ.Doe@insilicomedicine.com
42%
First@insilicomedicine.comJohn@insilicomedicine.com
29%
First.Last@insilicomedicine.comJohn.Doe@insilicomedicine.com
13%
Last@insilicomedicine.comDoe@insilicomedicine.com
8%
FLast@insilicomedicine.comJDoe@insilicomedicine.com
5%
First.L@insilicomedicine.comJohn.D@insilicomedicine.com
2%
Middle@insilicomedicine.comMichael@insilicomedicine.com
1%
First@insilico.comJohn@insilico.com
39%
First.Last@insilico.comJohn.Doe@insilico.com
38%
Last@insilico.comDoe@insilico.com
14%
F.Last@insilico.comJ.Doe@insilico.com
9%

Frequently Asked Questions

Where is Insilico Medicine's headquarters located?

Minus sign iconPlus sign iconInsilico Medicine's main headquarters is located at 1000 Massachusetts Ave Boston, Massachusetts 02138 US. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is Insilico Medicine's phone number?

Minus sign iconPlus sign icon You can contact Insilico Medicine's main corporate office by phone at
+1-443-451-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Insilico Medicine's official website and social media links?

Minus sign iconPlus sign iconInsilico Medicine's official website is insilico.com and has social profiles on LinkedIn.

How much revenue does Insilico Medicine generate?

Minus sign iconPlus sign icon As of April 2025, Insilico Medicine's annual revenue reached $75M.

What is Insilico Medicine's SIC code NAICS code?

Minus sign iconPlus sign iconInsilico Medicine's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Insilico Medicine have currently?

Minus sign iconPlus sign iconAs of April 2025, Insilico Medicine has approximately 283 employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: D. Y.Chief Executive Officer: S. C.Chief Business Officer: M. C.. Explore Insilico Medicine's employee directory with LeadIQ.

What industry does Insilico Medicine belong to?

Minus sign iconPlus sign iconInsilico Medicine operates in the Biotechnology Research industry.

What technology does Insilico Medicine use?

Minus sign iconPlus sign iconInsilico Medicine's tech stack includes Linkedin Insight TagTildaGoogle Font APITensorFlowDDoS-GuardGoogle Tag ManagerBootstrapGoogle Analytics.

What is Insilico Medicine's email format?

Minus sign iconPlus sign iconInsilico Medicine's email format typically follows the pattern of . Find more Insilico Medicine email formats with LeadIQ.

How much funding has Insilico Medicine raised to date?

Minus sign iconPlus sign icon As of April 2025, Insilico Medicine has raised $359M in funding. The last funding round occurred on Jan 11, 2022 for $255M.

When was Insilico Medicine founded?

Minus sign iconPlus sign iconInsilico Medicine was founded in 2014.
Insilico Medicine

Insilico Medicine

Biotechnology ResearchMassachusetts, United States201-500 Employees

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Section iconCompany Overview

Headquarters
1000 Massachusetts Ave Boston, Massachusetts 02138 US
Phone number
+1-443-451-****
Website
insilico.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $359M

    Insilico Medicine has raised a total of $359M of funding over 6 rounds. Their latest funding round was raised on Jan 11, 2022 in the amount of $255Mas a Series C.

  • $50M$100M

    Insilico Medicine's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $359M

    Insilico Medicine has raised a total of $359M of funding over 6 rounds. Their latest funding round was raised on Jan 11, 2022 in the amount of $255Mas a Series C.

  • $50M$100M

    Insilico Medicine's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    D. Y.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Q. Z.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. A. S.
    Vice President Clinical Development
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. Y.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. R.
    Founder Of Anti-Ageing & Wellness
    Phone icon
    Mobile Phone
  • Stylized image of a person
    O. W.
    Executive Assistant To Cbo / Bd Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Q. Z.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Chief Executive Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.